Showing 481 - 500 results of 1,014 for search 'development reprogramming', query time: 0.10s Refine Results
  1. 481

    Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities by Changjing Cai, Yiting Liu, Ruohuang Lu, Xudong Fan, Shan Zeng, Pingping Gan

    Published 2025-06-01
    “…This work offers essential insights for reprogramming platelets to shift their function from tumor promotion to tumor suppression, providing a foundation for the development of novel immunotherapeutic strategies and related research.…”
    Get full text
    Article
  2. 482

    The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets by Xiufeng Wang, Cong Luo, Danying Zhang

    Published 2025-08-01
    “…Challenges like CAF plasticity and biomarker development are discussed, alongside future directions for precision targeting in OS.…”
    Get full text
    Article
  3. 483

    Innate immune memory in macrophage differentiation and cardiovascular diseases by Yukiteru Nakayama, Katsuhito Fujiu

    Published 2025-06-01
    “…Advancing the understanding of these processes could facilitate the development of novel approaches to control inflammatory diseases and immune-related disorders.…”
    Get full text
    Article
  4. 484
  5. 485

    Constructing Cell-Specific Causal Networks of Individual Cells for Depicting Dynamical Biological Processes by Xinzhe Huang, Luonan Chen, Xiaoping Liu

    Published 2025-01-01
    “…It also enables the construction of context-specific GRNs to identify key regulators of fate transitions for diverse processes such as cellular reprogramming and development. Furthermore, SiCNet can delineate the intricate dynamic regulatory processes involved in development, providing deep insights into the mechanisms governing cellular transitions and the gene regulation across developmental stages.…”
    Get full text
    Article
  6. 486

    Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities by Lan Huang, Xuemei Chen, Meina Yan, Ze Xiang, Jian Wu

    Published 2025-07-01
    “…Epigenetic alterations and metabolic reprogramming are prominent characteristics of tumors. …”
    Get full text
    Article
  7. 487

    Regulatory role and therapeutic prospect of lactate modification in cancer by Mengdi Sun, Kejing Wang, Fang Lu, Donghua Yu, Shumin Liu

    Published 2025-02-01
    “…PTMs play a crucial role in processes such as signal transduction, epigenetics, and disease development. Lactylation is a newly discovered PTM that, due to its close association with lactate—the end product of glycolytic metabolism—provides a new perspective on the connection between cellular metabolic reprogramming and epigenetic regulation. …”
    Get full text
    Article
  8. 488

    Purine metabolism-associated key genes depict the immune landscape in gout patients by Lin-na Li, Hao Wang, Lu-shan Xiao, Wei-nan Lai

    Published 2025-02-01
    “…Therefore, our study made an urgent appeal to due attention to the underlying crosstalk among purine metabolism, immune responses, and tumor development in gout patients.…”
    Get full text
    Article
  9. 489

    Single-cell RNA sequencing reveals key regulators and differentiation trajectory of iPSC-derived cardiomyocytes by Lu Li, Dandan Li, Jiahong Wang, Yong Dai

    Published 2024-11-01
    “…Abstract Cardiac differentiation of human pluripotent stem cells is not only a new strategy of regenerative therapy for cardiovascular disease treatment but also provides unique opportunities for the study of in vitro disease models and human heart development. To elucidate the dynamic gene regulatory networks and pivotal regulators involved in the cardiomyocyte differentiation process, we conducted an analysis of single-cell RNA sequencing data obtained from the reprogramming of two human induced pluripotent stem cell (iPSC) lines into cardiomyocytes. …”
    Get full text
    Article
  10. 490

    Neuroprotection Mechanisms in Cerebral Hypothermia (Review) by Oleg A. Shevelev, Marina V. Petrova, Shavkat Kh. Saidov, Nadezhda A. Khodorovich, Pranil Pradkhan

    Published 2019-12-01
    “…The review focuses on the neuroprotective mechanisms of therapeutic hypothermia from the standpoint of metabolic depression and genomic reprogramming of neurons that develop when brain temperature decreases.The concept of hypothermic pre-conditioning based on the development of typical nonspecific reactions for the formation of the cytoprotective phenotype of neurons due to potentially dangerous stimuli, such as ischemia, reperfusion, and hypothermia, was used to explain the effects of low temperatures. …”
    Get full text
    Article
  11. 491

    Targeting the hallmarks of aging: mechanisms and therapeutic opportunities by Fumihiro Sanada, Shinichiro Hayashi, Ryuichi Morishita

    Published 2025-07-01
    “…Advances in regenerative medicine, gene editing, and organ cross-talk modulation are also contributing to the development of personalized, multi-targeted anti-aging therapies. …”
    Get full text
    Article
  12. 492

    Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma by H. Degroote, A. Van Dierendonck, A. Geerts, H. Van Vlierberghe, L. Devisscher

    Published 2018-01-01
    “…The heterogeneity of TAM subtypes and their origin and dynamic phenotype during the initiation and progression of HCC has been partially unraveled and forms the base for the development of therapeutic agents. Current approaches are aimed at decreasing the population of TAMs by depleting macrophages present in the tumor, blocking the recruitment of bone marrow-derived monocytes, and/or functionally reprogramming TAMs to antitumoral behavior. …”
    Get full text
    Article
  13. 493

    Tumour-infiltrating lymphocyte therapy landscape: prospects and challenges by Arkadiusz Z Dudek, Jeffrey Johnson, Ruqin Chen, Ali Rezazadeh

    Published 2025-08-01
    “…This review comprehensively examines the historical development, biology, clinical efficacy, safety and limitations of TIL therapy. …”
    Get full text
    Article
  14. 494

    Metabolic shifts in lipid utilization and reciprocal interactions within the lung metastatic niche of triple-negative breast cancer revealed by spatial multi-omics by Jung-Yu Kan, Hsiao-Chen Lee, Ming-Feng Hou, Hung-Pei Tsai, Shu-Fang Jian, Chao-Yuan Chang, Pei-Hsun Tsai, Yi-Shiuan Lin, Ying-Ming Tsai, Kuan-Li Wu, Yung-Chi Huang, Ya-Ling Hsu

    Published 2024-12-01
    “…Our findings revealed an increase in metabolic-related genes within the cancer cells, with the hub gene Dlat (Dihydrolipoamide S-Acetyltransferase) showing a significant association with the development of lung metastatic tumors. Upregulation of Dlat led to the reprogramming of fatty acid utilization, markedly enhancing the bioenergetic capacity of cancer cells. …”
    Get full text
    Article
  15. 495

    Knowledge mapping of trained immunity/innate immune memory: Insights from two decades of studies by Jiacheng He, Hongxia Cui, Guoqian Jiang, Lijun Fang, Jianlei Hao

    Published 2024-12-01
    “…The current research focus encompasses immune memory, nonspecific effects, epigenetics, metabolic reprogramming, BCG vaccine, and the development of trained immunity-based vaccines. …”
    Get full text
    Article
  16. 496

    METTL3 inhibits primed-to-naïve transition of pluripotent stem cells through m6A-YTHDF2-pluripotency/Gstp1 mRNA degradation axis by Sa Li, Jiajie Hao, Guangliang Hong, Hongzhi Dong, He Liu, Lingmei Jin, Zhihao Zhang, Haoyu Wu, Mingli Hu, Rujin Huang, Guanzheng Luo, Jiangping He, Jiekai Chen, Kaixin Wu

    Published 2025-05-01
    “…Abstract N6-methyladenosine (m6A) plays crucial roles in development and cellular reprogramming. During embryonic development, pluripotency transitions from a naïve to a primed state, and modeling the reverse primed-to-naïve transition (PNT) provides a valuable framework for investigating pluripotency regulation. …”
    Get full text
    Article
  17. 497

    Phosphofructokinase-1 redefined: a metabolic hub orchestrating cancer hallmarks through multi-dimensional control networks by Rong Yuan, Junqi Wang, Shengkang Zhang, Zhaojun Xu, Lan Song

    Published 2025-08-01
    “…The isoform-specific modification networks unveil novel targets for developing diagnostic biomarkers and tissue-selective therapeutic strategies. …”
    Get full text
    Article
  18. 498

    Research progress on the role and mechanisms of microglia in inflammatory diseases of central nervous system by YU Kai, SHUAI Zhewei, HUANG Hongjun, LUO Yan

    Published 2025-05-01
    “…In recent years, with the rapid development of frontier biotechnology such as single-cell sequencing, proteinomics and gene editing, important progress has been made in understanding the molecular mechanism by which microglia participate in CNS inflammatory diseases, especially in the activation of inflammatory corpuscles, epigenetic modifications, and metabolic reprogramming. …”
    Get full text
    Article
  19. 499

    Blimp1/Prdm1 Functions in Opposition to Irf1 to Maintain Neonatal Tolerance during Postnatal Intestinal Maturation. by Arne W Mould, Marc A J Morgan, Andrew C Nelson, Elizabeth K Bikoff, Elizabeth J Robertson

    Published 2015-07-01
    “…Recent studies demonstrate that the zinc finger transcriptional repressor Blimp1/Prdm1 plays an essential role governing postnatal reprogramming of intestinal enterocytes during this period. …”
    Get full text
    Article
  20. 500

    The complement system in human pregnancy and preeclampsia by Vijay Kumar, John H. Stewart

    Published 2025-08-01
    “…For a successful pregnancy, maternal immune reprogramming is crucial because the developing embryo is considered a semi-allograft. …”
    Get full text
    Article